Home » Analyst Articles – US
Brookline Bancorp (NASDAQ:BRKL) Stock Rating Lowered by Keefe, Bruyette & Woods
Keefe, Bruyette & Woods downgraded shares of Brookline Bancorp (NASDAQ:BRKL – Free Report) from an outperform rating to a market perform rating in a research note published on Tuesday, MarketBeat Ratings reports. They currently... More of this article »
Mattel (NASDAQ:MAT) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of Mattel (NASDAQ:MAT – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday. MAT has been the subject of a number of other reports. DA Davidson restated... More of this article »
O’Reilly Automotive (NASDAQ:ORLY) Lowered to Hold Rating by StockNews.com
StockNews.com lowered shares of O’Reilly Automotive (NASDAQ:ORLY – Free Report) from a buy rating to a hold rating in a research note published on Tuesday. A number of other research analysts have also weighed in on ORLY.... More of this article »
Maiden (NASDAQ:MHLD) Lowered to Sell Rating by StockNews.com
StockNews.com downgraded shares of Maiden (NASDAQ:MHLD – Free Report) from a hold rating to a sell rating in a report published on Tuesday morning. Maiden Stock Down 0.8 % MHLD opened at $1.32 on Tuesday. The firm’s fifty... More of this article »
National Bankshares (NASDAQ:NKSH) Downgraded by StockNews.com to Sell
StockNews.com cut shares of National Bankshares (NASDAQ:NKSH – Free Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday morning. Separately, Janney Montgomery Scott upgraded National... More of this article »
Golar LNG (NASDAQ:GLNG) Price Target Raised to $55.00 at Stifel Nicolaus
Golar LNG (NASDAQ:GLNG – Free Report) had its price target raised by Stifel Nicolaus from $53.00 to $55.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the shipping... More of this article »
Enanta Pharmaceuticals (NASDAQ:ENTA) Given New $18.00 Price Target at HC Wainwright
Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) had its price objective reduced by HC Wainwright from $27.00 to $18.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on... More of this article »
Fluent (NASDAQ:FLNT) Now Covered by Analysts at StockNews.com
Equities researchers at StockNews.com began coverage on shares of Fluent (NASDAQ:FLNT – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock. Fluent Trading Down... More of this article »